Cancer Biology & Medicine: 21 (5)

Index by author

May 15, 2024; Volume 21,Issue 5

Open Access
Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition
Can Xu, Pengyu Hou, Xiang Li, Menglin Xiao, Ziqi Zhang, Ziru Li, Jianglong Xu, Guoming Liu, Yanli Tan and Chuan Fang

Cancer Biology & Medicine May 2024, 21 (5) 363-381; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0510

Open Access
Development of small molecule drugs targeting immune checkpoints
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, Yujie Ouyang, Chuan Xu and Ying Shi

Cancer Biology & Medicine May 2024, 21 (5) 382-399; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0034

Open Access
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma and Zhiming Shao

Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0492
Open Access
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
Yuexiang Liang, Guannan Sheng, Yu Guo, Yiping Zou, Hanhan Guo, Zhifei Li, Shaofei Chang, Quan Man, Song Gao and Jihui Hao

Cancer Biology & Medicine May 2024, 21 (5) 416-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0363
Open Access
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuanyuan Chen and Ming Chen

Cancer Biology & Medicine May 2024, 21 (5) 433-444; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0373